Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5-year analysis of DASFREE

  1. Shah, N.P.
  2. García-Gutiérrez, V.
  3. Jiménez-Velasco, A.
  4. Larson, S.M.
  5. Saussele, S.
  6. Rea, D.
  7. Mahon, F.-X.
  8. Levy, M.Y.
  9. Gómez-Casares, M.T.
  10. Mauro, M.J.
  11. Sy, O.
  12. Martin-Regueira, P.
  13. Lipton, J.H.
Aldizkaria:
British Journal of Haematology

ISSN: 1365-2141,  0007-1048

Argitalpen urtea: 2023

Alea: 202

Zenbakia: 5

Orrialdeak: 942-952

Mota: Artikulua

DOI: 10.1111/BJH.18883 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus